Mechanistically-based blood proteomic markers may be able to stratify risk for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer worldwide but is often diagnosed at an advanced incurable stage. Yet, despite the urgent need for blood-based biomarkers for early detection, ...
Feb 12, 2024
0
0